clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00946192 |
P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
P17 | country | United States of America | Q30 |
P582 | end time | 2019-12-01 | |
P4135 | maximum age | 21 | |
P1050 | medical condition | amenorrhea | Q334655 |
P2899 | minimum age | 14 | |
P1132 | number of participants | 230 | |
P4844 | research intervention | progesterone | Q26963 |
calcium oxalate | Q412399 | ||
desogestrel | Q415304 | ||
P6153 | research site | Massachusetts General Hospital | Q126412 |
P580 | start time | 2009-05-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes |
Search more.